GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zhejiang Huakang Pharmaceutical Co Ltd (SHSE:605077) » Definitions » Total Stockholders Equity

Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Total Stockholders Equity : ¥3,327 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Zhejiang Huakang Pharmaceutical Co Total Stockholders Equity?

Zhejiang Huakang Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥3,327 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Zhejiang Huakang Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥10.88. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Zhejiang Huakang Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.84.


Zhejiang Huakang Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Zhejiang Huakang Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huakang Pharmaceutical Co Total Stockholders Equity Chart

Zhejiang Huakang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 939.52 2,434.44 2,655.81 3,089.43 3,243.43

Zhejiang Huakang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,178.43 3,081.60 3,139.36 3,243.43 3,326.51

Zhejiang Huakang Pharmaceutical Co  (SHSE:605077) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Zhejiang Huakang Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Zhejiang Huakang Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Huakang Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Zhejiang Huakang Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Huakang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Huagong Road, Huabu Town, Zhejiang Province, Kaihua County, Quzhou, CHN, 324302
Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.
Executives
Zheng Xiao Yang Director
Wu Zhi Ping Director
Du Yong Rui Director
Zheng Fang Ming senior management
Jiang Xue Song Supervisors
Yu Jian Ming Directors, senior managers
Chen De Shui Directors, senior managers
Xu Xiao Rong Director
Cheng Xin Ping Directors, senior managers
Yan Xiao Xing Supervisors
Cao Jian Hong Director

Zhejiang Huakang Pharmaceutical Co Headlines

No Headlines